How A Failed Alzheimer’s Drug Illustrates The Drug Industry’s Gambling Problem
16:17 EDT 8 Aug 2012 | Forbes
On Monday, , , and Pharmaceuticals announced that the Alzheimer’s drug they were developing together had yielded such a bad result in a clinical trial that they were stopping all further work on it – dashing hopes for the 5 million Americans suff..
Original Article: How A Failed Alzheimer’s Drug Illustrates The Drug Industry’s Gambling Problem
More From BioPortfolio on "How A Failed Alzheimer’s Drug Illustrates The Drug Industry’s Gambling Problem"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
